SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Bitcoins selloff amid concerns over a reported Binance security breach is weighing on Strategy shares, with traders debating whether the crypto-market shock signals deeper trouble or a buying opportunity. Concerns about Strategys quarterly results and CFO transition add to the bearish discussion, while some investors expect a rebound.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCaths Medicare add-on reimbursement could decline sharply after the first quarter of 2027 has fueled concern about pricing and CorMedixs largest revenue driver, alongside a steep selloff. Traders disagree on whether the comments signal a lasting revenue threat or are preliminary, DaVita-specific estimates with limited visibility into future reimbursement and utilization.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX has reached fresh 52-week highs, with traders focused on an expected Q3 earnings report and debating whether the rally reflects BRIUMVI growth expectations or speculative buyout hopes and short covering. The buyout talk remains unconfirmed, and the earnings date has not been officially confirmed.

Whirlpool Corp. engages in the manufacturing and marketing of home appliances. Its products include home laundry appliances, refrigerators and freezers, cooking appliances, home dishwashers, and room air-conditioning equipment, mixers, and portable household appliances. The firm's brands include Whirlpool, KitchenAid, Maytag, Consul, Brastemp, Amana, Bauknecht, JennAir, and Indesit. It operates through the following geographical segments: Major Domestic Appliances (MDA) North America, Major Domestic Appliances (MDA) Latin America, Small Domestic Appliances (SDA) Global, and Others. The company was founded by Emory Upton, Fred Upton, and Louis C. Upton on November 11, 1911 and is headquartered in Benton Harbor, MI.

Whirlpool Corp.

Whirlpools weak Q1 results, sharply reduced full-year outlook and dividend suspension have driven attention, as the company cited recession-level appliance demand and blamed the Iran war and collapsing consumer confidence. Many traders are alarmed by the worsening outlook and debt burden, while some see the selloff as an overreaction and are buying for a possible rebound.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

Weaker 2027 Medicare Advantage star ratings for Aetna are driving concern about lost bonus payments and future margin pressure. Traders are comparing CVSs weakness with Humanas rally on improved ratings, while debating whether the setback is already priced in.

Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Traders are focused on a possible update on Corvuss ALPS program around the ASH abstract release and a company call, though the timing and whether the data will be disclosed remain uncertain. Optimism about a potential catalyst is countered by concerns over past delays, managements limited updates and heavy short interest.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

RASONQUE (daraxonrasib), Revolution Medicines pancreatic cancer therapy, remains the main focus: traders cite its Phase 3 survival results and FDA approval as support for the companys commercial and broader RAS-drug pipeline prospects. Discussion is also divided over valuation and efficacy across KRAS subtypes, with some traders pointing to competition from selective G12D drugs such as Verastems VS-7375.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances updated NSCLC trial results and shift toward biomarker-selected lung-cancer studies are driving attention: the overall response rate was 24.6%, while a retrospective subgroup showed a stronger signal, but the lung-cancer filing is expected in 2027 and durability remains uncertain. Traders are divided between viewing the selloff as an overreaction to promising precision-treatment data and seeing a narrower, delayed opportunity compounded by managements confusing presentation.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples fiscal fourth-quarter earnings report is the focus, with traders debating whether its premium valuation can be justified amid memory-cost pressures and concerns about iPhone demand and upgrade cycles. Some expect a sharp post-report drop, while others view Apples restrained AI spending and relative resilience during the tech selloff as supporting its safe-haven appeal.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowheads interim ARO-MAPT resultsshowing substantial tau reduction and supporting subcutaneous delivery of RNAi to the central nervous systemare a major focus. Traders broadly view the data as encouraging platform validation, but many are frustrated that the share price has not reflected the positive results and debate whether the weakness is market-driven or a sell-the-news reaction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

11 Communication Services Stocks Moving In Monday's Intraday Session

Gainers

Optimum Communications (NYSE:OPTU) stock rose 12.0% to $0.74 during Monday's regular session. The company's market cap stands at $228.9 million.
Treasure Global (NASDAQ:TGL) shares rose 11.64% toread more...

12 Communication Services Stocks Moving In Monday's Pre-Market Session

Gainers

Treasure Global (NASDAQ:TGL) stock increased by 55.2% to $0.34 during Monday's pre-market session.
Global Interactive (NASDAQ:GITS) stock increased by 12.52% to $1.4. The market value of their outstandingread more...

10 Communication Services Stocks Moving In Wednesday's Intraday Session

Gainers

Antelope Enterprise Hldgs (NASDAQ:AEHL) shares rose 198.2% to $25.5 during Wednesday's regular session. The company's market cap stands at $176.2 million.
Treasure Global (NASDAQ:TGL) shares movedread more...

Treasure Global’s New Medical Supply Alliance Puts a Massive Regional Market in Focus

Treasure Global (NASDAQ:TGL) stated, yesterday, that it signed a memorandum of understanding with Singapore-based Union Concept Trading to explore the sourcing, marketing and distribution of medical solutions and pharmaceutical products across Malaysia and selected regional markets. The proposed collaboration would combine Treasure Global’s digital commerce and regional distribution capabilities with Union Concept’s healthcare sourcing, manufacturing and regulatory expertise.

Treasure Global (TGL) Stock Soars Over 31% After-Hours: Here's What's Going On

Treasure Global shares jumped 31.58% after hours Tuesday after the company announced a $2 million software enhancement agreement.read more...

12 Communication Services Stocks Moving In Tuesday's After-Market Session

Gainers

NIP Group (NASDAQ:NIPG) shares rose 5.9% to $0.29 during Tuesday's after-market session. The company's market cap stands at $31.7 million.
Treasure Global (NASDAQ:TGL) shares increased by 5.0% to $4.3.read more...

Treasure Global Secures Malaysian Government Contractor Award – Firm To Develop AI Listening System That Will Run On Nvidia-Powered Infrastructure

Equity

The company said it will develop a platform that will process large volumes of unstructured digital conversations into meaningful intelligence.

TGL Stock Soars After Reappointment Of Former CEO Sam Teo 

Treasure Global announced that its former CEO Sam Teo would return as acting Chief Executive Officer from April 1. 

Treasure Global Promotes Insider As New CFO After Chan See Wah Exit 

Treasure Global announced that Pusparajan a/l Vadiveloo would assume the role of the new Chief Financial Officer.

What's Going On With Treasure Global Stock Wednesday?

Treasure Global shares are trading lower Wednesday after the company announced a $2.5 million registered direct offering of 250,000 shares.read more...

Treasure Global, Inc. engages in the provision of payment solutions. The firm created an online-to-offline (O2O) e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs. It operates through the ZCITY Platform and Customized Software Development Service segments. The company was founded by Kok Pin Tan on March 20, 2020 and is headquartered in New York, NY.

Treasure Global Inc

Bullish Sentiment

<ul class="summary-bullets"><li>The platform will be able to produce outputs such as real-time sentiment analysis, trend detection, and behavioral insights.</li><li>Last week, the company forecast revenue for fiscal 2026 to more than double.</li><li>For fiscal 2027, the company intends to concentrate on scaling its user and merchant base across the ZCITY super app.</li></ul>Malaysia-based Treasure Global (TGL) announced on Thursday that it has secured a $15 million contract from Creative World Industries, a government contractor, to develop an AI-integrated platform that can process large volumes of online chats into data that can be used for marketing intelligence, brand management, and customer experience decision-making.<h1 class="st-heading-1">What Would The Social Listening AI System Do?</h1>The company said it will develop a platform that will process “large volumes of unstructured digital conversations” into meaningful intelligence using AI models, machine learning, and predictive analytics.The platform will leverage chip giant Nvidia’s GPU infrastructure to process “millions of digital interactions” and produce outputs such as real-time sentiment analysis, trend detection, and behavioral insights.“We are seeing strong market demand for AI systems that turn complex digital data into real-time intelligence,” said Sam Teo, acting CEO of the company. “This engagement strengthens our position in a rapidly growing market and supports our strategy to scale high-value, AI-driven solutions across multiple industries.”<h1 class="st-heading-1">Leadership Change At TGL</h1>In April this year, Sam Teo returned to Treasure Global as acting CEO, taking over responsibilities from Carlson Thow, who then assumed the position of executive director. Notably, Teo returned to assume the top post at the company after initially stepping down in June 2024.Last week, the company issued preliminary expectations for fiscal 2026, forecasting revenue to more than double and concentrating its focus on scaling user and merchant base across its ZCITY super app in fiscal 2027.<h1 class="st-heading-1">What Do Retail Traders Think About TGL?</h1>On Stocktwits, retail sentiment around TGL stock improved from ‘neutral’ to ‘extremely bullish’ over the past 24 hours amid ‘extremely high’ message volumes.One user on the platform wondered about the stock’s downward trajectory despite a positive catalyst.<stembedurl>https://stocktwits.com/Jay_Trades_/message/656105667</stembedurl><a href="https://stocktwits.com/symbol/TGL">TGL stock</a> is down more than 27% so far this year and nearly 83% over the past 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stock market down on a black background. (Source: Getty Images))

Malaysia-based Treasure Global (TGL) announced on Thursday that it has secured a $15 million contract from Creative World Industries, a government contractor, to develop an AI-integrated platform that can process large volumes of online chats into data th

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '25	--	-$350.00	--	N/A
Q3 '24	-$7000.00	-$2.32	99.97%	BEAT
Q2 '24	-$0.08	-$2.10	-2525.00%	MISSED
Q1 '24	-$0.13	-$0.11	15.38%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

TGL Earnings

Upcoming Earnings: Q1 '25

Historical Earnings